P//A

Aging is the biggest risk factor for chronic disease.

The science to delay or reverse it is accelerating, but roadblocks—from funding gaps to regulatory hurdles—are slowing progress.

Phoenix Aerie exists to help break these barriers.

Funding

Funding

  • Global investments in healthy longevity are insufficient to address aging demographics

  • Government and philanthropic funding for longevity research remains disproportionately low

  • Aging-focused research often requires longer timelines than traditional investors are willing to tolerate

Science

Longevity research is still considered niche, but that sentiment is shifting rapidly.

Bottlenecks in the research include:

  • Reduced influx of fresh ideas

  • Low interconnectivity 

  • A dearth of new talent

  • A lack of enough tools to analyze and tackle the issue from a variety of different angles

Translation

  • Therapeutics, biomarkers, and interventions often get stuck due to lack of funding, poor startup guidance, or unclear FDA pathways

  • Scientists are rarely trained in how to navigate biotech entrepreneurship or apply their research outside of academia.

  • Aging interventions often lack clear clinical endpoints, making it difficult to design trials that demonstrate effectiveness and secure regulatory approval.

Perception & Policy &

Perception & Policy &

Public perception still views aging’s negative effects as inevitable, not as solvable problems.

  • Without a cultural shift, longevity efforts remain underfunded and prioritized

  • Aging itself is not classified as a treatable condition, forcing longevity therapeutics to be tested against individual diseases rather than aging-related decline as a whole

  • Even if interventions prove effective, there is no established medical infrastructure to support longevity-focused treatments

Our Solution?

Build. Connect. Accelerate.

Build. Connect. Accelerate.

  • P//A curates a community of scientists, founders, and visionaries who push each other to think bigger and move faster.

  • Residents engage in real-world problem-solving in and beyond academia—their ideas sharpened through a variety of professional approaches and schools of thought.

  • P//A connects residents with emerging tools like decentralized science (DeSci), AI-driven discovery, and alternative funding models to push the boundaries of longevity research and biotech innovation

  • Through P//A and their work, residents actively contribute to science communication, public discourse, and regulatory discussions to accelerate field-wide progress.